Effectiveness of risk minimisation measures for valproate: A drug utilisation study in Europe.

MLA

Toussi, Massoud, et al. “Effectiveness of Risk Minimisation Measures for Valproate: A Drug Utilisation Study in Europe.” Pharmacoepidemiology and Drug Safety, vol. 30, no. 3, Mar. 2021, pp. 292–303. EBSCOhost, https://doi.org/10.1002/pds.5166.

APA

Toussi, M., Shlaen, M., Coste, F., de Voogd, H., Dimos, V., & Kaplan, S. (2021). Effectiveness of risk minimisation measures for valproate: A drug utilisation study in Europe. Pharmacoepidemiology and Drug Safety, 30(3), 292–303. https://doi.org/10.1002/pds.5166

Chicago

Toussi, Massoud, Margarita Shlaen, Florence Coste, Hanka de Voogd, Vasilis Dimos, and Sigal Kaplan. 2021. “Effectiveness of Risk Minimisation Measures for Valproate: A Drug Utilisation Study in Europe.” Pharmacoepidemiology and Drug Safety 30 (3): 292–303. doi:10.1002/pds.5166.